Applying genomic and transcriptomic advances to mitochondrial medicine.

Macken, William L; Vandrovcova, Jana; Hanna, Michael G; Pitceathly, Robert D S

Macken, William L; Vandrovcova, Jana; Hanna, Michael G; Pitceathly, Robert D S.

Affiliation

Macken WL; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.
Vandrovcova J; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.
Hanna MG; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.
Pitceathly RDS; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK. r.pitceathly@ucl.ac.uk.

Nat Rev Neurol ; 17(4): 215-230, 2021 04.

Article in En | MEDLINE | ID: mdl-33623159

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Mitochondrial / Genetic Testing / Sequence Analysis / Genomics / Mitochondrial Diseases / Molecular Diagnostic Techniques / Transcriptome Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Nat Rev Neurol Journal subject: NEUROLOGIA Year: 2021 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google